Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed2
Other4

Role Distribution

Principal Investigator1
Other Roles5
PI Rate17%

Activity Timeline

Clinical Trials (6)

NCT06243666Active Not Recruiting
Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection
PrincipalinvestigatorStart date: 2024-02-20
The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female
Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection+2 more
StudychairStart date: 2021-04-13
The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female
Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection+2 more
StudychairStart date: 2021-03-30
Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)
Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection+2 more
StudychairStart date: 2021-02-06
NCT03206255Completed
Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection+2 more
StudychairStart date: 2017-07-01
NCT02562508Phase 3Completed
A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection+2 more
StudychairStart date: 2015-12-05

Research Network

Collaboration Network

5 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yuemei Hu, Bachelor

Jiangsu Provincial Centre for Disease Control and Prevention

Similar
3 trials

Shared therapeutic areas:

Cancer of the Uterine CervixUterine Cervical DysplasiaPersistent Infection+2 more

Worked with same sponsors:

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.Jun Zhang+2 more
Collaborated on 2 trials
Similarity Score58%

Jun Zhang, MSc

Xiamen University

Moderately Similar
1 trials

Shared therapeutic areas:

Cancer of the Uterine CervixUterine Cervical DysplasiaPersistent Infection

Worked with same sponsors:

Center for Disease Control and Prevention, Sheyang County, Yancheng City, Jiangsu Province, ChinaXiamen Innovax Biotech Co., Ltd+1 more
Collaborated on 1 trial
Similarity Score34%

Jun Zhang, master

Xiamen University

Moderately Similar
12 trials

Shared therapeutic areas:

Cancer of the Uterine CervixUterine Cervical DysplasiaPersistent Infection+2 more

Worked with same sponsors:

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.Jun Zhang+2 more
Similarity Score30%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Cancer of the Uterine CervixUterine Cervical Dysplasia
Similarity Score12%

Juntao Ran

LanZhou University

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score6%

Xiaojie Ma

Affiliated Hospital of North Sichuan Medical College

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score6%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score6%

Xiaoying Xue

The Second Hospital of Hebei Medical University

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score6%

Ciro Gallo, M.D., Ph.D.

University of Campania Luigi Vanvitelli

Related
8 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score6%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT06243666PrincipalInvestigator

Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls

Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection
Active Not Recruiting
NCT05045755StudyChair

The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection+2 more
Unknown
NCT04969445StudyChair

The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection+2 more
Unknown
NCT04704908StudyChair

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)

Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection+2 more
Unknown
NCT03206255StudyChair

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection+2 more
Completed
NCT02562508Phase 3StudyChair

A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection+2 more
Completed

All 6 trials loaded